Cheat sheet

RRB Pharmacist Cheat Sheet

Practice this exam

Professional Ability — Pharmacy

  • 70% of exam
  • Pharmacology Pharmaceutics Analysis and chemistry Pharmacognosy Law and practice Microbiology and biotechnology Quality and research Novel delivery

General Science

  • 10% of exam
  • Physics Chemistry Life sciences CBSE Class 10

General Awareness

  • 10% of exam
  • Current affairs Polity History and geography Economy and environment

Arithmetic, Intelligence & Reasoning

  • 10% of exam
  • Number systems Time and work Interest and percentages Logic and data

Quick Facts

  • Reference CEN 05/2026; check official updates
  • Questions 100 objective CBT questions
  • Duration 90 minutes; eligible PwBD 120
  • Indicative section questions 70 professional; 10/10/10 common
  • Wrong answer One-third allotted mark deducted
  • UR/EWS minimum 40%
  • OBC(NCL)/SC and ST minimum 30% and 25% respectively
  • PwBD relaxation Conditional 2 marks; not selection guarantee
  • Age 20–35 as of 1 January 2027
  • Medical C2 standard; official assessment required
  • Fee ₹500 general; ₹250 specified concessions
  • Recruitment status Check unified official RRB notices
  • Coverage 50 cards are selected, partial revision

Alkaloid Screening Colors PR

  • Dragendorff orange; Mayer cream; Wagner brown; Hager yellow
  • Screening only; interferences possible Confirm identity by specified methods

Ester vs Amide Anesthetics PR

Ester example: procaine

  • Often plasma-esterase metabolism
  • PABA-related metabolites possible

Amide example: lidocaine

  • Often hepatic metabolism
  • Articaine also has ester group
  • Formulation determines heat/sterilization suitability

Clinical Interpretation Picker PR

  • Paracetamol overdose, even late → Assess NAC indication promptly ( No automatic 8-hour exclusion )
  • Organophosphate respiratory secretions → Atropine with ventilation/decontamination ( Pupils alone are not endpoint )
  • INH patient at neuropathy risk → Use preventive pyridoxine guidance ( Population and regimen still matter )
  • Troponin above reference limit → Identify myocardial injury ( MI also requires ischemic evidence )
  • Possible medicine-related harm → Document and report suspected ADR ( Proof of causation not prerequisite )

Pharmacology & Toxicology PR

  • Paracetamol overdose NAC supports glutathione; early treatment matters
  • Late overdose presentation Assess treatment; no 8-hour exclusion
  • Organophosphate bronchorrhea Atropine; ventilation; safe decontamination
  • Pralidoxime Enzyme reactivation before agent-dependent aging
  • ACE-inhibitor cough Bradykinin accumulation; assess alternatives
  • Isoniazid neuropathy prevention Risk-based pyridoxine; not universal dosing
  • Phenytoin Capacity-limited metabolism; nonlinear dose–concentration relationship
  • Vinca alkaloids Inhibit tubulin assembly
  • Taxanes Stabilize microtubules against disassembly
  • Experimental pharmacology Controls and ethical approval constrain inference

Parasympathetic Outflow PR

  • III VII IX X plus S2–S4
  • Cranial and sacral outflows Acetylcholine is not exclusively parasympathetic

Schedule H1 vs Schedule X PR

H1

  • Separate supply register
  • Records retained 3 years

X

  • Duplicate retail prescription
  • Copy retained 2 years
  • Statutory lists; other laws may overlap

Schedule & Licence Picker PR

  • Schedule H1 retail supply → Separate register; 3 years
  • Schedule X prescription → Retain duplicate copy 2 years
  • Ordinary retail/wholesale sale → Forms 20/20B ( Excludes C, C(1) and X )
  • C/C(1) retail/wholesale sale → Forms 21/21B ( Excludes Schedule X )
  • Pharmacist annual retention → Follow council process before 1 April ( Where directed; fee is council-specific )
  • Historical 1955 excise question → Distinguish historical scheme from repeal ( CGST section 174; savings apply )

Pharmaceutics & Physical Principles PR

  • Powder fineness Edition-specific sieve apertures and passing fractions
  • Low HLB More lipophilic; W/O tendency
  • Higher HLB More hydrophilic; O/W tendency
  • Capping Tablet crown separates
  • Lamination Tablet separates into layers
  • Type I glass Borosilicate; high hydrolytic resistance
  • Glass suitability Formulation compatibility; not route alone
  • Lyophilization Freezing; sublimation; desorption
  • Dissolution versus disintegration Drug entering solution versus tablet breakup
  • Suspension sedimentation Particle size, viscosity and density matter
  • Engineering heat transfer Conduction, convection and radiation differ
  • Industrial scale-up Validate process; preserve critical quality attributes

Vitamin Deficiency Associations PR

  • Niacin: dermatitis diarrhea dementia; B12: anemia plus neurologic risk
  • Pernicious anemia is one B12 cause Folate alone can mask B12 anemia

Historical Excise vs Current Law PR

1955 Act terminology

  • Bonded: duty-controlled historical manufacture
  • Non-bonded: historical duty-paid framework

Current legal status

  • 1955 Act repealed by CGST
  • Section 174 savings preserve prior matters
  • Historical levy; current repeal and savings

Test & Quality Interpretation Picker PR

  • Positive Benedict urine test → Consider reducing substances ( Not specific for glucose )
  • Negative urine nitroprusside result → Do not exclude DKA ( Beta-hydroxybutyrate detection is inadequate )
  • Colored alkaloid precipitate → Treat as preliminary screening ( Not a specific identity assay )
  • Batch passes finished testing → Still assess QA/GMP compliance ( Testing alone cannot assure every attribute )
  • Analytical result outside specification → Investigate through approved procedure ( Do not discard inconvenient results )

Analysis & Medicinal Chemistry PR

  • Limit test Compare with specified reference preparation
  • Iron thioglycolic method Colored ferrous complex; monograph-specific conditions
  • Procaine Ester; PABA-related metabolites possible
  • Lidocaine Amide; mainly hepatic metabolism
  • Articaine Amide with additional ester group
  • Sterilization suitability Licensed formulation; not class label
  • Phenothiazine SAR Series-dependent trends; not universal exclusions
  • Aluminum antacids Constipation tendency; renal accumulation risk
  • Magnesium antacids Diarrhea tendency; renal accumulation risk
  • Chromatography Separates through differential phase interactions
  • Calibration Relates signal to reference concentrations
  • Analytical validation Specificity, accuracy, precision and range

ABC vs VED Inventory Analysis PR

ABC

  • Annual consumption value
  • Illustrative bands vary

VED

  • Clinical criticality
  • Vital, essential, desirable
  • Cost priority and clinical priority differ

Pharmacognosy & Herbal Quality PR

  • Dragendorff reagent Orange-red alkaloid precipitate; screening only
  • Mayer reagent Creamy-white alkaloid precipitate; screening only
  • Wagner reagent Reddish-brown alkaloid precipitate; screening only
  • Hager reagent Yellow alkaloid precipitate; screening only
  • Borntrager principle Anthraquinone-associated colored alkaline phase
  • Modified Borntrager Some resistant C-glycosides need modification
  • Digitalis lanata Digoxin association; Plantaginaceae
  • Digitalis purpurea Digitoxin association; older family names differ
  • Herbal standardization Identity, content, contaminants and consistency
  • Adulteration Substitution or contamination compromises quality
  • Nutraceutical claim Not automatic drug approval or efficacy
  • Dietary supplements Interactions and dose-related harms remain possible

Current Law & Historical Terminology PR

  • Schedule H1 Separate supply register; retain 3 years
  • Schedule X Duplicate prescription; retain copy 2 years
  • Schedule G Specified medical-supervision caution
  • Schedule M Current pharmaceutical GMP requirements
  • Schedule P Listed shelf life and storage
  • Schedule T Ayurvedic, Siddha and Unani GMP
  • Forms 20 and 20B Ordinary retail and wholesale respectively
  • Forms 21 and 21B C/C(1); X excluded 21 retail; 21B wholesale; X excluded
  • Pharmacy Act section 34 Retention fee before 1 April Where state annual-renewal direction applies
  • 1955 excise Act Repealed by CGST section 174 Historical syllabus terminology; statutory savings
  • Clinical trials/new drugs NDCT Rules 2019 defined scope
  • Marketing authorization Product-specific permission; not promotional proof

Biochemistry, Anatomy & Pathophysiology PR

  • Benedict test Reducing substances; not glucose-specific
  • Nitroprusside ketones Does not adequately detect beta-hydroxybutyrate
  • Pernicious anemia Autoimmune intrinsic-factor-related B12 malabsorption
  • Other B12 deficiency Dietary, intestinal, surgical and medicine causes
  • Troponin elevation Myocardial injury; not automatically infarction
  • Acute MI diagnosis Acute injury plus evidence of ischemia
  • Proximal tubule Major reabsorption; glucose transport saturates
  • GFR Varies with age, size and disease
  • SA node Normally fastest spontaneous pacemaker
  • Parasympathetic outflow III, VII, IX, X; S2–S4
  • Biopharmaceutics Dosage form affects drug availability
  • Half-life interpretation Model and elimination conditions matter

Pharmacy Practice & Inventory PR

  • Unit-dose system Patient-specific packaged doses; interval varies
  • P&T committee Formulary and safe medication-use governance
  • Automatic stop orders Approved policy; clinical review and notification
  • ABC analysis Annual consumption value; bands are illustrative
  • VED analysis Vital, essential, desirable clinical criticality
  • EOQ assumptions Stable demand/costs; consistent time units
  • EOQ formula Square root of 2DS/H
  • Current ratio Current assets / current liabilities
  • Quick ratio Liquid current assets / current liabilities
  • Ratios limitation Benchmarks do not guarantee solvency
  • Reduced-osmolarity ORS 245 mOsm/L when correctly prepared
  • ORS sachet dilution Use the specified water volume

Microbiology & Biotechnology PR

  • Sterilization versus disinfection All viable microbes versus reduction targets
  • Asepsis Prevents contamination; not a sterilization guarantee
  • Gram classification Cell-wall staining distinction; not susceptibility proof
  • Antimicrobial stewardship Appropriate agent, indication, dose and duration
  • Culture result Interpret with clinical sampling context
  • Vaccine mechanism Induces active immune response
  • Antibody administration Provides passive immunity
  • Biologic quality Identity, purity, potency and consistency
  • Biotechnology product Manufacturing changes can affect attributes
  • Environmental pharmacy Prevent unsafe medicine and waste disposal

Quality, Research & Regulatory Science PR

  • Quality assurance System preventing quality failures
  • Quality control Sampling/testing against specifications
  • GMP documentation Traceable, contemporaneous and controlled records
  • Deviation investigation Assess cause, impact and corrective action
  • Change control Evaluate and approve changes prospectively
  • Pharmacovigilance Detect, assess and prevent medicine harms
  • ADR signal Possible association; not causation proof
  • Random allocation Reduces systematic allocation differences
  • Blinding Reduces selected observation/performance biases
  • P value Not probability hypothesis is true
  • Confidence interval Method-dependent estimate uncertainty range
  • Informed consent Voluntary, informed participation; ethics oversight

Delivery, Molecular Biology & Marketing PR

  • Bioavailability Rate/extent reaching systemic circulation
  • First-pass effect Presystemic metabolism can reduce availability
  • Controlled release Designed release; do not crush automatically
  • Targeted delivery Intended selectivity; not guaranteed exclusivity
  • Liposome Lipid-bilayer vesicle carrier
  • DNA versus RNA Deoxyribose versus ribose nucleic acids
  • Transcription DNA information copied into RNA
  • Translation mRNA information guides protein synthesis
  • Computer-aided drug design Models support hypotheses; require validation
  • Cosmetic versus medicine Intended claims/function affect regulatory classification
  • Pharma marketing ethics Accurate claims; avoid unsupported superiority
  • Computer applications Validate calculations and protect patient data

Xylem vs Phloem GE

Xylem

  • Mainly water and minerals
  • Roots-to-shoots movement predominates

Phloem

  • Organic assimilate transport
  • Source to sink; direction varies
  • Transport function differs from tissue location

Class 10 General Science GE

  • Thin-lens Cartesian formula 1/f + 1/u = 1/v
  • Mirror Cartesian formula 1/f = 1/v + 1/u
  • Series resistors Add resistances; same current
  • Parallel resistors Add conductances; same branch voltage
  • Plaster of Paris Calcium sulfate hemihydrate
  • Gypsum Calcium sulfate dihydrate
  • One-unit pH decrease Tenfold hydrogen-ion activity increase
  • Glycolysis Net 2 ATP per glucose
  • Aerobic ATP yield Accounting-dependent; no universal 36–38
  • Xylem Mainly water and mineral transport
  • Phloem Source-to-sink assimilate transport
  • Enamel critical pH Approximately 5.5; conditions alter threshold

Himalayan vs Peninsular Rivers GE

Himalayan systems

  • Snow/glacier and rainfall contributions
  • Large trans-state/international basins

Peninsular systems

  • Rainfall and storage strongly influence flow
  • Narmada/Tapi are major west-flowing examples
  • No absolute perennial/seasonal rule

Indian Polity, Geography & Awareness GE

  • Fundamental Rights Part III; principally Articles 12–35
  • Directive Principles Part IV; Articles 36–51
  • Fundamental Duties Part IVA; Article 51A
  • GST Council Article 279A
  • Panchayats 73rd Amendment; Part IX
  • Municipalities 74th Amendment; Part IXA
  • Southern Railway headquarters Chennai; not a terminal name
  • South Central Railway headquarters Secunderabad
  • Narmada and Tapi Major west-flowing peninsular rivers
  • PM-JAY cover ₹5 lakh yearly; eligible family
  • Current affairs Use dated official releases
  • Freedom struggle Distinguish movements, chronology and regional context

Alphabet Positions AR

  • E J O T Y: 5 10 15 20 25
  • Opposite letters have position sum 27 Use the stated coding pattern

Quantitative Formula Picker AR

  • Filler and drain together → Subtract independent rates ( Check net rate is positive )
  • Complete train passing → Total lengths / relative speed ( Convert to consistent units )
  • Two-year annual CI−SI → Use P×r²/10,000 ( Not monthly-compounding shortcut )
  • Successive markup and discount → Multiply price-change factors ( Percentages use different bases )
  • Dividing a financial ratio → Check liabilities are nonzero ( No fixed solvency guarantee )

Arithmetic & Logic Conditions AR

  • Tank fill versus drain Subtract rates; positive net required
  • 6-hour fill, 9-hour drain 1/18 tank/hour; 18 hours
  • Opposing trains Add speeds; use total lengths
  • Same-direction trains Positive speed difference; equal means no-pass
  • Annual 10%; ₹10,000; 2 years CI−SI = ₹100
  • Annual 10%; ₹10,000; 3 years CI−SI = ₹310
  • 25% markup, 20% discount Break-even before other costs
  • km/h to m/s Multiply by 5/18
  • All-S-are-P contradictory Some S are not P
  • No-S-are-P contradictory Some S are P
  • Empty-category caution Universal statements need not imply existence
  • Data sufficiency Determine uniqueness, not merely plausibility

Common Traps

Timing Benefit vs Exclusion Rule

  • Early NAC treatment benefit ≠ Universal 8-hour treatment cutoff

Different Record Retention

  • H1 register: 3 years ≠ X prescription copy: 2 years

Historical vs Current Law

  • Historical 1955 excise scheme ≠ Unchanged current national excise regime

Class vs Product Compatibility

  • Glass hydrolytic-resistance class ≠ Proof of formulation compatibility

Injury vs Ischemic Infarction

  • Troponin-defined myocardial injury ≠ Automatically proven myocardial infarction

Qualifying vs Appointment

  • Minimum qualifying marks ≠ Guaranteed appointment

Section vs Internal Subject Weights

  • 70% Professional Ability section ≠ Published internal pharmacy-subject weights

Last Minute

  • 1. CBT: 100 questions, 90 minutes
  • 2. Indicative Professional Ability: 70 marks
  • 3. Indicative common sections: 10 marks each
  • 4. Wrong answer deducts one-third mark
  • 5. Eligible PwBD time: 120 minutes
  • 6. UR/EWS minimum: 40%
  • 7. OBC(NCL)/SC minimum: 30%
  • 8. ST minimum: 25%
  • 9. Conditional PwBD relaxation: 2 marks
  • 10. H1 register: retain 3 years
  • 11. X prescription copy: retain 2 years
  • 12. Troponin injury does not prove MI
  • 13. NAC has no 8-hour exclusion
  • 14. ORS osmolarity: 245 mOsm/L
  • 15. Series resistances add
  • 16. Parallel conductances add
  • 17. 25% markup/20% discount: break-even
  • 18. Annual CI compounds interest on interest
  • 19. Simple interest excludes interest on interest
  • 20. Equal-speed trains have zero relative speed

RRB Pharmacist Recruitment Exam

  • Practice Questions 100 questions Cheat Sheet 152 facts Flashcards 50 cards Games 20 terms Podcast
  • Word games 20 terms Guess the Term T E R M S Read the clue and guess the term in 6 tries. Word games 20 terms Term Match Swap tiles to line up three of the same term. Word games 20 terms Term Pairs ? ✓ ✓ ? ? Flip two cards at a time to find matching terms. Word games 20 terms Term Search Q T E R M X Find five hidden terms in a grid of letters.

Same family resources

  • Explore More India Pharmacy Registration Exams
  • Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

DPEE

  • Practice Questions 100 questions Shorts 1 short

DSSSB Pharmacist Recruitment Exam

  • Practice Questions 100 questions

ESIC Pharmacist Recruitment Exam

  • Practice Questions 100 questions

NIPER JEE (NIPER Joint Entrance Exam)

  • Practice Questions 100 questions

SSC Pharmacist Recruitment Exam

  • Practice Questions 100 questions

UPSC Drug Inspector Examination

  • Practice Questions 100 questions Shorts 1 short